Patent · US Active

Process for preparation of montelukast sodium

US9487487B2 · kind B2 · utility

1Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2013
Grant dateNov 8, 2016
Priority date
Expiry dateMay 17, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a process for the preparation of montelukast sodium. The process comprises a) reacting 2-(2-(3(S)-(3-(2-(7-chloro-2-quinolinyl)-ethenyl)phenyl)-3-hydroxypropyl)phenyl)-2-propanol with methane sulfonyl chloride and coupling the resultant mesylate compound with 1-(mercaptomethyl)cyclopropane acetic acid in presence of a base and free alkali source followed by saltification with an amine in a single step reaction and b) converting the montelukast amine salt to montelukast sodium salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.